2-((3,4-dimethoxyphenyl)(hydroxy)methyl)-1,4-dihydroxyanthracene-9,10-dione

ID: ALA4567917

PubChem CID: 155560682

Max Phase: Preclinical

Molecular Formula: C23H18O7

Molecular Weight: 406.39

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C(O)c2cc(O)c3c(c2O)C(=O)c2ccccc2C3=O)cc1OC

Standard InChI:  InChI=1S/C23H18O7/c1-29-16-8-7-11(9-17(16)30-2)20(25)14-10-15(24)18-19(23(14)28)22(27)13-6-4-3-5-12(13)21(18)26/h3-10,20,24-25,28H,1-2H3

Standard InChI Key:  AIZSNTQOPWWPHD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    4.8077  -11.6635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8077  -10.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1025  -11.2591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1050  -10.4437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4013  -10.0356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6945  -10.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6959  -11.2602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4002  -11.6647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5130  -10.4419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5114  -11.2573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2156  -11.6646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9219  -11.2576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9196  -10.4391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2148  -10.0355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8063   -9.2120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8089  -12.4807    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2150  -12.4817    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2128   -9.2183    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6260  -10.0282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6234   -9.2111    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3315  -10.4336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3327  -11.2519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0409  -11.6582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7483  -11.2472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7430  -10.4258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0343  -10.0233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4480  -10.0125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1584  -10.4163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4578  -11.6526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4616  -12.4698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  2  1  0
  3  1  1  0
  1 10  1  0
  9  2  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  2 15  2  0
  1 16  2  0
 11 17  1  0
 14 18  1  0
 13 19  1  0
 19 20  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 19 21  1  0
 25 27  1  0
 27 28  1  0
 24 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4567917

    ---

Associated Targets(Human)

TOP2A Tclin DNA topoisomerase II (1334 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 406.39Molecular Weight (Monoisotopic): 406.1053AlogP: 2.97#Rotatable Bonds: 4
Polar Surface Area: 113.29Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.49CX Basic pKa: CX LogP: 4.31CX LogD: 4.28
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.45Np Likeness Score: 0.76

References

1. Liu Y, Liang Y, Jiang J, Qin Q, Wang L, Liu X..  (2019)  Design, synthesis and biological evaluation of 1,4-dihydroxyanthraquinone derivatives as anticancer agents.,  29  (9): [PMID:30846253] [10.1016/j.bmcl.2019.02.026]

Source